Tower Research Capital LLC TRC cut its position in shares of HCA Healthcare Inc (NYSE:HCA) by 24.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,938 shares of the company’s stock after selling 1,591 shares during the period. Tower Research Capital LLC TRC’s holdings in HCA Healthcare were worth $668,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in HCA. Westside Investment Management Inc. purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $34,000. NEXT Financial Group Inc purchased a new position in HCA Healthcare in the second quarter worth approximately $43,000. Rational Advisors LLC lifted its stake in HCA Healthcare by 5,118.2% in the first quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after acquiring an additional 563 shares during the last quarter. Cornerstone Advisors Inc. lifted its stake in HCA Healthcare by 19.6% in the first quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock worth $77,000 after acquiring an additional 96 shares during the last quarter. Finally, Alpha Windward LLC lifted its stake in HCA Healthcare by 50.9% in the second quarter. Alpha Windward LLC now owns 608 shares of the company’s stock worth $89,000 after acquiring an additional 205 shares during the last quarter. 70.19% of the stock is owned by hedge funds and other institutional investors.
HCA has been the subject of a number of recent research reports. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price target for the company. in a research note on Monday, May 27th. Stephens set a $150.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Bank of America upgraded shares of HCA Healthcare from an “underperform” rating to a “neutral” rating and lifted their price target for the stock from $130.00 to $137.00 in a research note on Friday, September 6th. Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $147.00 to $160.00 in a research note on Wednesday, July 10th. Finally, Mizuho set a $153.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. HCA Healthcare currently has a consensus rating of “Buy” and an average target price of $155.29.
In other news, SVP Robert A. Waterman sold 33,786 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 977 shares of HCA Healthcare stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $127.56, for a total transaction of $124,626.12. Following the completion of the transaction, the senior vice president now directly owns 11,484 shares in the company, valued at $1,464,899.04. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by company insiders.
HCA stock traded down $3.25 during midday trading on Tuesday, reaching $125.70. 512,044 shares of the company were exchanged, compared to its average volume of 1,329,383. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $147.42. The stock’s 50-day simple moving average is $125.73 and its 200 day simple moving average is $128.92. The company has a market cap of $43.41 billion, a price-to-earnings ratio of 12.87, a price-to-earnings-growth ratio of 1.10 and a beta of 0.87.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The company had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. During the same period in the previous year, the business posted $2.29 EPS. The firm’s revenue for the quarter was up 9.3% compared to the same quarter last year. As a group, sell-side analysts predict that HCA Healthcare Inc will post 10.4 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 dividend on an annualized basis and a yield of 1.27%. HCA Healthcare’s payout ratio is currently 16.38%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: How to execute a trade ex-dividend strategy?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.